Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("COOPER, Curtis")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

Hepatitis C Treatment Highlights From the 2011 American Association for the Study of Liver Disease MeetingCOOPER, Curtis.Clinical infectious diseases. 2012, Vol 55, Num 3, pp 418-425, issn 1058-4838, 8 p.Article

An Overview of HIV and Chronic Viral Hepatitis Co-InfectionCOOPER, Curtis L.Digestive diseases and sciences. 2008, Vol 53, Num 4, pp 899-904, issn 0163-2116, 6 p.Article

Comparison of first antiretroviral treatment duration and outcome in hiv, HIV-HBV and HIV-HCV infectionCOOPER, Curtis L; MILLS, Ed.International journal of STD & AIDS. 2007, Vol 18, Num 8, pp 546-550, issn 0956-4624, 5 p.Article

The influence of race and language on chronic hepatitis C virus infection managementGIORDANO, Céline; COOPER, Curtis.European journal of gastroenterology & hepatology. 2009, Vol 21, Num 2, pp 131-136, issn 0954-691X, 6 p.Article

Dynamic meteorology at the photosphere of HD 209458bCOOPER, Curtis S; SHOWMAN, Adam P.The Astrophysical journal. 2005, Vol 629, Num 1, pp L45-L48, issn 0004-637X, 2Article

Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infectionCOOPER, Curtis L; MILLS, Edward; ANGEL, Jonathan B et al.AIDS (London). 2007, Vol 21, Num 1, pp 71-76, issn 0269-9370, 6 p.Article

Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfectionCOOPER, Curtis L; CAMERON, D. William.Clinical infectious diseases. 2002, Vol 35, Num 7, pp 873-879, issn 1058-4838Article

Obstacles to Successful HCV Treatment in Substance Addicted PatientsCOOPER, Curtis L.Journal of addictive diseases. 2008, Vol 27, Num 2, pp 61-68, issn 1055-0887, 8 p.Article

Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infectionCOOPER, Curtis L; CAMERON, D. William.AIDS (London). 2004, Vol 18, Num 2, pp 337-338, issn 0269-9370, 2 p.Article

Dynamics and disequilibrium carbon chemistry in hot jupiter atmospheres, with application to HD 209458bCOOPER, Curtis S; SHOWMAN, Adam P.The Astrophysical journal. 2006, Vol 649, Num 2, pp 1048-1063, issn 0004-637X, 16 p., 1Article

Therapeutic interventions for HIV infection and chronic viral hepatitisCOOPER, Curtis L.Clinical infectious diseases. 2005, Vol 41, pp S69-S72, issn 1058-4838, SUP1Article

ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCVFERENCI, Peter; BERNSTEIN, David; BOX, Terry D et al.The New England journal of medicine. 2014, Vol 370, Num 21, pp 1983-1992, issn 0028-4793, 10 p.Article

Influenza vaccine Oculorespiratory syndrome incidence is reduced in HIVCOOPER, Curtis; THORNE, Anona.Vaccine. 2011, Vol 29, Num 45, pp 7876-7877, issn 0264-410X, 2 p.Article

CTN-194 (PICCO) : Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapyKLEIN, Marina B; COOPER, Curtis; BROUILLETTE, Marie-Josée et al.Contemporary clinical trials. 2008, Vol 29, Num 4, pp 617-630, issn 1551-7144, 14 p.Article

Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatmentKELLY, Erin M; CORACE, Kimberly; EMERY, Joel et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 7, pp 811-816, issn 0954-691X, 6 p.Article

Rate of infectious complications during interferon- based therapy for hepatitis C is not related to neutropeniaCOOPER, Curtis L; AL-BEDWAWI, Saif; LEE, Craig et al.Clinical infectious diseases. 2006, Vol 42, Num 12, pp 1674-1678, issn 1058-4838, 5 p.Article

Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomesGIORDANO, Céline; DRUYTS, Eric F; GARBER, Gary et al.European journal of gastroenterology & hepatology. 2009, Vol 21, Num 9, pp 963-968, issn 0954-691X, 6 p.Article

Influence of Laboratory Methods on Calcareous Saline Soils for EC Measurement and LeachingCOOPER, Curtis A; DAVIS, Jessica G; CARDON, Grant E et al.Communications in soil science and plant analysis. 2008, Vol 39, Num 3-4, pp 329-343, issn 0010-3624, 15 p.Article

Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCOOPER, Curtis L; PARBHAKAR, M. A; ANGEL, Jonathan B et al.Clinical infectious diseases. 2002, Vol 34, Num 9, pp 1259-1263, issn 1058-4838Article

Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohortNDUMBI, Patricia; GILLIS, Jennifer; TSOUKAS, Chris M et al.AIDS (London). 2013, Vol 27, Num 18, pp 2863-2872, issn 0269-9370, 10 p.Article

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV―HCV-coinfected individualsKLEIN, Marina B; ROLLET, Kathleen C; HULL, Mark et al.Antiviral therapy (London). 2013, Vol 18, Num 5, pp 717-721, issn 1359-6535, 5 p.Article

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C VirusHULL, Mark W; ROLLET, Kathleen; ODUEYUNGBO, Adefowope et al.Clinical infectious diseases. 2012, Vol 54, Num 12, pp 1798-1805, issn 1058-4838, 8 p.Article

Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda : a qualitative studyOLUPOT-OLUPOT, Peter; KATAWERA, Andrew; COOPER, Curtis et al.AIDS (London). 2008, Vol 22, Num 14, pp 1882-1884, issn 0269-9370, 3 p.Article

Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinicBALFOUR, Louise; COOPER, Curtis; TASCA, Giorgio A et al.Canadian journal of public health. 2004, Vol 95, Num 4, pp 272-277, issn 0008-4263, 6 p.Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

  • Page / 3